CXCR4 and breast carcinoma: Inhibiting CXCR4 expression in breast cancer cells, using different strategies (e.g., siRNA silencing, phenotypic CXCR4 knockout, peptide inhibitor of protein kinease-α), also suppressed breast cancer metastasis (38–40).